Artgen Biotech PJSC (MIC:ABIO) Price-to-Operating-Cash-Flow : 41.03 (As of May. 25, 2024)

View and export this data going back to 2006. Start your Free Trial

What is Artgen Biotech PJSC Price-to-Operating-Cash-Flow?

As of today (2024-05-25), Artgen Biotech PJSC's share price is ₽103.10. Artgen Biotech PJSC's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was ₽2.51. Hence, Artgen Biotech PJSC's Price-to-Operating-Cash-Flow Ratio for today is 41.03.

The historical rank and industry rank for Artgen Biotech PJSC's Price-to-Operating-Cash-Flow or its related term are showing as below:

MIC:ABIO' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 4.4 Med: 30.62 Max: 425.41
Current: 42.88

During the past 13 years, Artgen Biotech PJSC's highest Price-to-Operating-Cash-Flow Ratio was 425.41. The lowest was 4.40. And the median was 30.62.

MIC:ABIO's Price-to-Operating-Cash-Flow is ranked worse than
66.55% of 290 companies
in the Biotechnology industry
Industry Median: 26.275 vs MIC:ABIO: 42.88

Artgen Biotech PJSC's Cash Flow from Operations per share for the six months ended in Jun. 2023 was ₽0.57. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was ₽2.51.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Artgen Biotech PJSC was -22.30% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 1.30% per year.

During the past 13 years, Artgen Biotech PJSC's highest 3-Year average Operating Cash Flow per Share Growth Rate was 719.30% per year. The lowest was -71.00% per year. And the median was 5.80% per year.

Artgen Biotech PJSC Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Artgen Biotech PJSC's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artgen Biotech PJSC Price-to-Operating-Cash-Flow Chart

Artgen Biotech PJSC Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

30.00

5.32

53.15

32.74

24.48

Artgen Biotech PJSC Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	32.74	-	24.48	-

Competitive Comparison of Artgen Biotech PJSC's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Artgen Biotech PJSC's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Artgen Biotech PJSC's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Artgen Biotech PJSC's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Artgen Biotech PJSC's Price-to-Operating-Cash-Flow falls into.

Artgen Biotech PJSC Price-to-Operating-Cash-Flow Calculation

Artgen Biotech PJSC's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	103.10	/	2.513
	=	41.03

Artgen Biotech PJSC's Share Price of today is ₽103.10.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Artgen Biotech PJSC's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was ₽2.51.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Artgen Biotech PJSC Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Artgen Biotech PJSC's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Artgen Biotech PJSC (MIC:ABIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Artgen Biotech PJSC (MIC:ABIO) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

Prospect of the 60th Anniversary, Moscow, RUS, 117036

Website

https://www.hsci.ru

Artgen Biotech PJSC formerly Human Stem Cells Institute PJSC is a biotechnology company. It is engaged in the drug discovery, research and development and marketing of proprietary products and services in the field of regenerative medicine, bio-insurance, medical genetics, including reproductive genetics, gene therapy, and biopharmaceutics. The company has developed Neovasculgen, which is a gene therapy drug for the treatment of Peripheral Arterial Disease, including Critical Limb Ischemia and also develops SPRS therapy which entails the use of autologous dermal fibroblasts to repair skin damage due to aging and other structural changes.